Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display

10P - Human papillomavirus integration testing and high-grade cytology improve diagnostic performance of colposcopy-guided biopsy

Date

20 Jun 2024

Session

Poster Display

Presenters

Han Xie

Citation

Annals of Oncology (2024) 9 (suppl_5): 1-7. 10.1016/esmoop/esmoop103497

Authors

H. Xie1, T. Hu2, L. Li1, X. Huang1, H. Zhou1, L. He1, L. Zhuang1

Author affiliations

  • 1 Tongji Hospital Affiliated Tongji Medical College of Huazhong University of Science and Technology, Wuhan/CN
  • 2 Tongji Hospital Affiliated Tongji Medical College of Huazhong, Wuhan/CN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 10P

Background

Our objective was to investigate the diagnostic efficacy of colposcopy-guided biopsy (CGB) and to explore new strategies to increase the accuracy for detecting cervical intraepithelial neoplasia grade 2 or more severe lesions.

Methods

We conducted a retrospective cohort study of 550 women who underwent both CGB and surgery to assess the consistency of their pathological findings. Using surgical pathology as the gold standard, we evaluated the diagnostic accuracy of CGB in detecting high-grade lesions. Univariate and multivariate logistic regression analyses were used to identify independent predictors for CIN2+ and CIN3+ lesions on definitive pathology. The AUC was utilized to evaluate the diagnostic performance of detecting CIN2+ and CIN3+ lesions on surgical pathology with various variables.

Results

Among 550 women with paired CGB/surgical pathology, 53.5% (294/550) had perfect agreement, with 17.1% (94/550) underestimations and 29.5% (162/550) overestimations. The sensitivity and specificity of CGB for detecting CIN2+ lesions were 86.3% (276/320) and 51.3% (118/230), respectively. Multivariate logistic analysis revealed that CGB confirming CIN2+ (OR, 6.0; 95% CI, 3.9-9.1; P < 0.001), high-grade cytology (OR, 2.6; 95% CI, 1.4-4.9; P = 0.003), and HPV integration-positive (OR, 2.2; 95% CI, 1.3-3.5; P < 0.001) were significant predictors for CIN2+ on surgical pathology. For identifying CIN3+, CGB confirming CIN2+ (OR, 5.3; 95% CI, 3.4-8.3; P < 0.001), high-grade cytology (OR, 2.6; 95% CI, 1.5-4.7; P = 0.001), HPV integration-positive (OR, 2.0; 95% CI, 1.3-3.1; P = 0.003) were independent predictors. The AUCs increased when incorporating several variables to predict high-grade lesions. For 27 patients with both high-grade-cytology and HPV integration-positive results, 25 (92.6%) of them confirmed CIN2+ on definitive pathology.

Conclusions

CGB's accuracy is limited, leading to underestimations and overestimations. Combining CGB with HPV integration and cytology enhances CIN2+ and CIN3+ diagnosis. Diagnostic conisation may be considered for patients with high-grade cytology and HPV integration-positive results.

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.